Search Results

Sakmar, Debbie L. Hay, Lukas Grätz, and more. Check out some of the latest GPCR discoveries below!

November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s new structure-based technology has passed a key test, in enabling the discovery of orally available small molecules aimed at intractable and poorly drugged membrane and complex-bound protein targets. The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases with high unmet need." Read more at the source #DrGPCR #GPCR #IndustryNews

coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang

Debbie Hay About this episode Dr. Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK. Join me and learn more about Debbie’s career and what she learned through her experiences as a scientist Debbie Hay on the web LinkedIn Wikipedia University of Otago University of Auckland Google Scholar Pubmed

Debbie Hay , University of Otago. Feb 2021 — Episode #27 released featuring Dr. Robert J.

Debbie Hay , Dr. Randy Hall , tributes to Dr. Marc Caron with over 30 guests including Dr.